|
1
|
The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for leukemogenesis.
|
Mutat Res
|
2008
|
1.04
|
|
2
|
Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia.
|
PLoS One
|
2009
|
1.03
|
|
3
|
Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers.
|
Mol Cancer
|
2009
|
0.88
|